Simplify Genomics

Executive Summary

Simplify Genomics is a San Diego-based genomics company that provides a proprietary genome search engine and analytical platform, the Smart Genome™ Platform, designed to accelerate clinical decision-making through rapid genomic reporting and exploration. The company operates a CLIA-certified, CAP-accredited dry laboratory for clinical whole genome sequencing reports, positioning itself as a key player in the precision medicine space. By enabling faster and more comprehensive genomic analysis, Simplify Genomics aims to reduce turnaround times for genetic insights, thereby improving patient outcomes in areas such as rare disease diagnosis, oncology, and pharmacogenomics. The company's platform leverages advanced algorithms to interpret complex genomic data, making it accessible to clinicians without requiring deep bioinformatics expertise. As genomics becomes increasingly integral to routine clinical care, Simplify Genomics is well-positioned to capture market share by addressing the critical need for efficient, scalable, and clinically actionable genomic interpretation.

Upcoming Catalysts (preview)

• Q3 2026Launch of Enhanced Platform Features for Rare Disease Diagnostics70% success
• Q4 2026Strategic Partnership with Major Hospital Network or Reference Laboratory60% success
• Q1 2027Publication of Clinical Validation Study in Peer-Reviewed Journal80% success